Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 123Triple Negative Breast Neoplasms 22Lung Neoplasms 17Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 11Brain Neoplasms 9Pancreatic Neoplasms 8Ovarian Neoplasms 8Melanoma 8Prostatic Neoplasms 7Colonic Neoplasms 7Carcinoma, Renal Cell 7Breast Neoplasms, Male 7Stomach Neoplasms 6Meningeal Carcinomatosis 6Colorectal Neoplasms 6Carcinoma, Intraductal, Noninfiltrating 6Esophageal Neoplasms 5Carcinoma, Hepatocellular 5Anatomic Stage IV Breast Cancer AJCC v8 5Small Cell Lung Carcinoma 4Neoplasms 4Fallopian Tube Neoplasms 4Breast Carcinoma In Situ 4Anatomic Stage III Breast Cancer AJCC v8 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Salivary Gland Neoplasms 3Rectal Neoplasms 3Inflammatory Breast Neoplasms 3

Interventions

trastuzumab biosimilar HLX02 1exemestane 1X-Rays 1Trastuzumab 1Taxes 1TVB-2640 1Specimen Handling 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Magnetic Resonance Spectroscopy 1Letrozole 1Fulvestrant 1Disulfides 1CT-P6 1Biopsy 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Carcinoma × Magnetic Resonance Spectroscopy × Breast × Clear all
NCT03179904 2026-05-05

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Mayo Clinic

Phase 2 Active not recruiting
17 enrolled 10 charts
Breast

Advanced Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡